Literature DB >> 24099110

Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone.

Chih-Hsien Liu1, Han-Ju Chen, Pa-Chun Wang, Huan-Sen Chen, Yen-Liang Chang.   

Abstract

The aim of the present study is to review the recurrence patterns and incidence of second primary tumors (SPTs) in patients with oral squamous cell carcinoma (OSCC) who underwent surgery alone without postoperative adjuvant therapy. Data on patients recorded in the head and neck cancer registry of Cathay General Hospital were reviewed. A total of 72 patients with T1-3N0 OSCC who underwent surgery alone were included. Among the 72 patients, 44 had T1 tumors, 22 had T2 tumors, and 6 had T3 tumors. The 5-year overall survival (OS) rate was 77.3%, the recurrence-free survival rate was 74.1%, and the SPT-free survival rate was 73%. Eighteen (25%) patients had disease recurrence (regional recurrence in nine patients, local recurrence in seven patients, and locoregional recurrence in two patients). Most patients with local recurrence alone (6/7 patients, 85.7%) could be salvaged with treatment. However, locoregional control was obtained in only five (45.5%) of 11 patients with neck recurrence after surgical salvage therapy. At the time of analysis, 20 patients developed SPTs, and 15 (75%) of the SPTs were in the oral cavity. The annual incidence of SPT was 5%. Neck recurrence and SPT were associated with 48.4% and 24.4% lower 5-year OS rates, respectively. Multivariate analysis revealed that neck recurrence was a significant risk factor for low OS (p = 0.008). Neck recurrence was the most important prognostic factor for OS. The incidence of SPT development was high. Regular and long-term monitoring for recurrence and development of SPTs is necessary to improve the survival rate.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Oral cancer; Prognostic factor; Recurrence; Second primary tumor surgery

Mesh:

Year:  2013        PMID: 24099110     DOI: 10.1016/j.kjms.2013.03.001

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  9 in total

1.  Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer.

Authors:  Ligia B Schmitd; Cindy Perez-Pacheco; Emily L Bellile; Weisheng Wu; Keith Casper; Michelle Mierzwa; Laura S Rozek; Gregory T Wolf; Jeremy M G Taylor; Nisha J D'Silva
Journal:  Clin Cancer Res       Date:  2022-08-15       Impact factor: 13.801

2.  Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: Retrospective study of 154 cases over 7 years in Qatar.

Authors:  Orwa Elaiwy; Walid El Ansari; Moustafa AlKhalil; Adham Ammar
Journal:  Ann Med Surg (Lond)       Date:  2020-10-20

3.  Role of Neck Dissection in Clinical T3N0M0 Lesion of Oral Cavity: Changing Trend.

Authors:  Arjun Dass; Surinder K Singhal; Rps Punia; Nitin Gupta; Hitesh Verma; Shilpi Budhiraja; Minakshi Salaria
Journal:  J Clin Diagn Res       Date:  2017-08-01

4.  Prospective study on factors affecting the prognosis of oral cancer in a Chinese population.

Authors:  Fengqiong Liu; Fa Chen; Jiangfeng Huang; Lingjun Yan; Fangping Liu; Junfeng Wu; Yu Qiu; Xiaoyan Zheng; Rongzhao Zhang; Lisong Lin; Baochang He
Journal:  Oncotarget       Date:  2017-01-17

5.  Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck.

Authors:  Tomohiro Enokida; Susumu Okano; Takao Fujisawa; Yuri Ueda; Shinya Uozumi; Makoto Tahara
Journal:  Front Oncol       Date:  2018-08-27       Impact factor: 6.244

6.  Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.

Authors:  Maria T Brands; Elisabeth A J Smeekens; Robert P Takes; Johannes H A M Kaanders; Andre L M Verbeek; Matthias A W Merkx; Sandra M E Geurts
Journal:  Cancer Med       Date:  2019-08-10       Impact factor: 4.452

7.  Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence.

Authors:  Yen-Yun Wang; Pen-Tzu Fang; Chang-Wei Su; Yuk-Kwan Chen; Joh-Jong Huang; Ming-Yii Huang; Shyng-Shiou F Yuan
Journal:  Oncol Lett       Date:  2021-04-07       Impact factor: 2.967

8.  Retrospective study on factors affecting the prognosis in oral cancer patients who underwent surgical treatment only.

Authors:  Byeong-Guk Kim; Jun-Hwa Kim; Myung-In Kim; Jeong Joon Han; Seunggon Jung; Min-Suk Kook; Hong-Ju Park; Sun-Youl Ryu; Hee-Kyun Oh
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-01-16

9.  Prognostic Indicators of Oral Squamous Cell Carcinoma.

Authors:  Girish Mysore Suresh; Ravi Koppad; B V Prakash; K S Sabitha; P S Dhara
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.